HIGH RISK PROSTATE CARCINOMA

Clinical trials for HIGH RISK PROSTATE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK PROSTATE CARCINOMA trials appear

Sign up with your email to follow new studies for HIGH RISK PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Trial tests Immune-Boosting drug to wipe out prostate cancer

Disease control Terminated

This study aimed to see if adding the immunotherapy drug pembrolizumab to standard hormone therapy and radiation could better eliminate cancer in men with high-risk prostate cancer that hasn't spread. The main goal was to check if a follow-up biopsy showed no cancer after treatme…

Matched conditions: HIGH RISK PROSTATE CARCINOMA

Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HIGH RISK PROSTATE CARCINOMA

Get alerted when new HIGH RISK PROSTATE CARCINOMA trials appear

Trial tests Immune-Boosting drug to wipe out prostate cancer